{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,9]],"date-time":"2026-01-09T23:42:25Z","timestamp":1768002145583,"version":"3.49.0"},"reference-count":58,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2020,9,4]],"date-time":"2020-09-04T00:00:00Z","timestamp":1599177600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100009634","name":"Susan G. Komen","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100009634","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100010261","name":"Thoracic Surgery Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100010261","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Immunol."],"DOI":"10.3389\/fimmu.2020.02027","type":"journal-article","created":{"date-parts":[[2020,9,4]],"date-time":"2020-09-04T04:29:02Z","timestamp":1599193742000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":6,"title":["HMGB1 Promotes Myeloid Egress and Limits Lymphatic Clearance of Malignant Pleural Effusions"],"prefix":"10.3389","volume":"11","author":[{"given":"Adam C.","family":"Soloff","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Katherine E.","family":"Jones","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Amy A.","family":"Powers","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pranav","family":"Murthy","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yue","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kira L.","family":"Russell","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Miranda","family":"Byrne-Steele","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Amanda W.","family":"Lund","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jian-Min","family":"Yuan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sara E.","family":"Monaco","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jian","family":"Han","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rajeev","family":"Dhupar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michael T.","family":"Lotze","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1965","published-online":{"date-parts":[[2020,9,4]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"975","DOI":"10.6004\/jnccn.2012.0102","article-title":"Optimal management of malignant pleural effusions (Results of CALGB 30102).","volume":"10","author":"Demmy","year":"2012","journal-title":"J Natl Compr Cancer Netw."},{"key":"B2","doi-asserted-by":"publisher","first-page":"1021","DOI":"10.3978\/j.issn.2072-1439.2015.04.23","article-title":"Pleural involvement in lung cancer.","volume":"7","author":"Agalioti","year":"2015","journal-title":"J Thorac Dis."},{"key":"B3","doi-asserted-by":"publisher","first-page":"697","DOI":"10.1164\/rccm.201310-1776OC","article-title":"Interplay of Th1 and Th17 cells in murine models of malignant pleural effusion.","volume":"189","author":"Lin","year":"2014","journal-title":"Am J Respir Crit Care Med."},{"key":"B4","first-page":"47","article-title":"Prognostic value of pleural effusion in patients with non-small cell lung cancer.","volume":"3","author":"Sugiura","year":"1997","journal-title":"Clin Cancer Res."},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.1080\/2162402X.2018.1554969","article-title":"Making cold malignant pleural effusions hot: driving novel immunotherapies.","volume":"8","author":"Murthy","year":"2019","journal-title":"Oncoimmunology."},{"key":"B6","doi-asserted-by":"publisher","first-page":"967","DOI":"10.1378\/chest.92.6.967","article-title":"Lack of association of pleural effusion with chronic pulmonary arterial and right atrial hypertension.","volume":"92","author":"Wiener-Kronish","year":"1987","journal-title":"Chest."},{"key":"B7","doi-asserted-by":"publisher","first-page":"1422","DOI":"10.1172\/JCI113747","article-title":"Relationship of pleural effusions to increased permeability pulmonary edema in anesthetized sheep.","volume":"82","author":"Wiener-Kronish","year":"1988","journal-title":"J Clin Invest."},{"key":"B8","doi-asserted-by":"publisher","first-page":"384","DOI":"10.1152\/jappl.1988.64.1.384","article-title":"Removal of pleural liquid and protein by lymphatics in awake sheep.","volume":"64","author":"Broaddus","year":"1988","journal-title":"J Appl Physiol."},{"key":"B9","doi-asserted-by":"publisher","first-page":"2623","DOI":"10.1152\/jappl.1990.68.6.2623","article-title":"Clearance of lung edema into the pleural space of volume-loaded anesthetized sheep.","volume":"68","author":"Broaddus","year":"1990","journal-title":"J Appl Physiol."},{"key":"B10","doi-asserted-by":"publisher","first-page":"585","DOI":"10.1152\/jappl.1988.65.2.585","article-title":"Alveolar liquid and protein clearance from normal dog lungs.","volume":"65","author":"Berthiaume","year":"1988","journal-title":"J Appl Physiol."},{"key":"B11","doi-asserted-by":"publisher","first-page":"331","DOI":"10.1038\/nri1594","article-title":"High-mobility group box 1 protein (HMGB1): nuclear weapon in the immune arsenal.","volume":"5","author":"Lotze","year":"2005","journal-title":"Nat Rev Immunol."},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2019.01561","article-title":"Johnny on the spot-chronic inflammation is driven by HMGB1.","volume":"10","author":"Gorgulho","year":"2019","journal-title":"Front Immunol."},{"key":"B13","doi-asserted-by":"publisher","first-page":"25","DOI":"10.4137\/CGM.S24314","article-title":"Pattern recognition receptors in cancer progression and metastasis.","volume":"8","author":"Pandey","year":"2015","journal-title":"Cancer Growth Metastasis."},{"key":"B14","doi-asserted-by":"publisher","first-page":"4046","DOI":"10.1158\/1078-0432.CCR-13-0495","article-title":"HMGB1 in cancer: good, bad, or both?","volume":"19","author":"Kang","year":"2013","journal-title":"Clin Cancer Res."},{"key":"B15","doi-asserted-by":"publisher","first-page":"3967","DOI":"10.1158\/0008-5472.CAN-12-0851","article-title":"Immunogenic tumor cell death induced by chemoradiotherapy in patients with esophageal squamous cell carcinoma.","volume":"72","author":"Suzuki","year":"2012","journal-title":"Cancer Res."},{"key":"B16","doi-asserted-by":"publisher","first-page":"4821","DOI":"10.1158\/0008-5472.CAN-11-0950","article-title":"Human tumor cells killed by anthracyclines induce a tumor-specific immune response.","volume":"71","author":"Fucikova","year":"2011","journal-title":"Cancer Res."},{"key":"B17","doi-asserted-by":"publisher","first-page":"1050","DOI":"10.1038\/nm1622","article-title":"Toll-like receptor 4-dependent contribution of the immune system to anticancer chemotherapy and radiotherapy.","volume":"13","author":"Apetoh","year":"2007","journal-title":"Nat Med."},{"key":"B18","doi-asserted-by":"publisher","first-page":"230","DOI":"10.1158\/0008-5472.CAN-11-2001","article-title":"HMGB1 promotes drug resistance in osteosarcoma.","volume":"72","author":"Huang","year":"2012","journal-title":"Cancer Res."},{"key":"B19","doi-asserted-by":"publisher","first-page":"1996","DOI":"10.1158\/0008-5472.CAN-11-2291","article-title":"p53\/HMGB1 complexes regulate autophagy and apoptosis.","volume":"72","author":"Livesey","year":"2012","journal-title":"Cancer Res."},{"key":"B20","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1038\/leu.2010.225","article-title":"HMGB1-induced autophagy promotes chemotherapy resistance in leukemia cells.","volume":"25","author":"Liu","year":"2011","journal-title":"Leukemia."},{"key":"B21","doi-asserted-by":"publisher","first-page":"409","DOI":"10.1016\/j.oraloncology.2011.12.009","article-title":"HMGB1 is overexpressed in tumor cells and promotes activity of regulatory T cells in patients with head and neck cancer.","volume":"48","author":"Wild","year":"2012","journal-title":"Oral Oncol."},{"key":"B22","doi-asserted-by":"publisher","first-page":"626","DOI":"10.1164\/rccm.201401-0140ED","article-title":"The lymphatic system in malignant pleural effusion. Drain or immune switch?","volume":"189","author":"Marazioti","year":"2014","journal-title":"Am J Respir Crit Care Med."},{"key":"B23","doi-asserted-by":"publisher","first-page":"3389","DOI":"10.1172\/JCI79434","article-title":"Lymphatic vessels regulate immune microenvironments in human and murine melanoma.","volume":"126","author":"Lund","year":"2016","journal-title":"J Clin Invest."},{"key":"B24","doi-asserted-by":"publisher","first-page":"3176","DOI":"10.1016\/j.celrep.2017.09.006","article-title":"Lymphatic vessels balance viral dissemination and immune activation following cutaneous viral infection.","volume":"20","author":"Loo","year":"2017","journal-title":"Cell Rep."},{"key":"B25","doi-asserted-by":"publisher","first-page":"2234","DOI":"10.1002\/ijc.31251","article-title":"Leukocyte telomere length in relation to risk of lung adenocarcinoma incidence: findings from the Singapore Chinese health study.","volume":"142","author":"Yuan","year":"2018","journal-title":"Int J Cancer."},{"key":"B26","doi-asserted-by":"publisher","first-page":"1518","DOI":"10.1073\/pnas.0913939107","article-title":"High throughput sequencing reveals a complex pattern of dynamic interrelationships among human T cell subsets.","volume":"107","author":"Wang","year":"2010","journal-title":"Proc Natl Acad Sci USA."},{"key":"B27","doi-asserted-by":"publisher","DOI":"10.1186\/s12967-019-1796-4","article-title":"High throughput sequencing of T-cell receptor repertoire using dry blood spots.","volume":"17","author":"Wu","year":"2019","journal-title":"J Transl Med."},{"key":"B28","doi-asserted-by":"publisher","first-page":"369","DOI":"10.1007\/978-1-4939-9773-2_17","article-title":"The adaptome as biomarker for assessing cancer immunity and immunotherapy.","volume":"2055","author":"Han","year":"2020","journal-title":"Methods Mol Biol."},{"key":"B29","first-page":"5013","article-title":"Elevated levels of HMGB1 in cancerous and inflammatory effusions.","volume":"29","author":"Winter","year":"2009","journal-title":"Anticancer Res."},{"key":"B30","doi-asserted-by":"publisher","DOI":"10.1016\/j.resp.2019.103330","article-title":"Expression of IL-1beta, HMGB1, HO-1, and LDH in malignant and non-malignant pleural effusions.","volume":"272","author":"Wu","year":"2020","journal-title":"Respir Physiol Neurobiol."},{"key":"B31","doi-asserted-by":"publisher","DOI":"10.1016\/j.molimm.2012.10.037","article-title":"HMGB1 and leukocyte migration during trauma and sterile inflammation.","volume":"55","author":"Venereau","year":"2013","journal-title":"Mol Immunol."},{"key":"B32","doi-asserted-by":"publisher","first-page":"518","DOI":"10.1016\/j.coi.2008.04.012","article-title":"HMGB1: a two-headed signal regulating tumor progression and immunity.","volume":"20","author":"Campana","year":"2008","journal-title":"Curr Opin Immunol."},{"key":"B33","doi-asserted-by":"publisher","first-page":"485","DOI":"10.1093\/intimm\/dxs051","article-title":"HMGB1 conveys immunosuppressive characteristics on regulatory and conventional T cells.","volume":"24","author":"Wild","year":"2012","journal-title":"Int Immunol."},{"key":"B34","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1159\/000218331","article-title":"Suppression of dendritic cells by HMGB1 is associated with lymph node metastasis of human colon cancer.","volume":"76","author":"Kusume","year":"2009","journal-title":"Pathobiology."},{"key":"B35","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2013.00068","article-title":"HMGB1: the central cytokine for all lymphoid cells.","volume":"4","author":"Li","year":"2013","journal-title":"Front Immunol."},{"key":"B36","doi-asserted-by":"publisher","first-page":"307","DOI":"10.4049\/jimmunol.173.1.307","article-title":"High mobility group box protein 1: an endogenous signal for dendritic cell maturation and Th1 polarization.","volume":"173","author":"Messmer","year":"2004","journal-title":"J Immunol."},{"key":"B37","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1016\/j.cytogfr.2006.01.003","article-title":"High-mobility group box 1 (HMGB1) protein: friend and foe.","volume":"17","author":"Ulloa","year":"2006","journal-title":"Cytokine Growth Factor Rev."},{"key":"B38","doi-asserted-by":"publisher","first-page":"629","DOI":"10.1158\/0008-5472.CAN-12-2704","article-title":"Tissue damage-associated \u201cdanger signals\u201d influence T-cell responses that promote the progression of preneoplasia to cancer.","volume":"73","author":"He","year":"2013","journal-title":"Cancer Res."},{"key":"B39","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.vetimm.2012.03.016","article-title":"Migration of gammadelta T cells in steady-state conditions.","volume":"147","author":"Shekhar","year":"2012","journal-title":"Vet Immunol Immunopathol."},{"key":"B40","doi-asserted-by":"publisher","first-page":"606","DOI":"10.1126\/science.aaa4282","article-title":"IMMUNODEFICIENCIES. Impairment of immunity to Candida and Mycobacterium in humans with bi-allelic RORC mutations.","volume":"349","author":"Okada","year":"2015","journal-title":"Science."},{"key":"B41","doi-asserted-by":"publisher","DOI":"10.1038\/ncomms9726","article-title":"Identification and characterization of latency-associated peptide-expressing gammadelta T cells.","volume":"6","author":"Rezende","year":"2015","journal-title":"Nat Commun."},{"key":"B42","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1016\/j.cell.2016.08.030","article-title":"Epithelia use butyrophilin-like molecules to shape organ-specific gammadelta T cell compartments.","volume":"167","author":"Di Marco Barros","year":"2016","journal-title":"Cell."},{"key":"B43","doi-asserted-by":"publisher","DOI":"10.1126\/scitranslmed.aao2966","article-title":"Human thymopoiesis is influenced by a common genetic variant within the TCRA-TCRD locus.","volume":"10","author":"Clave","year":"2018","journal-title":"Sci Transl Med."},{"key":"B44","doi-asserted-by":"publisher","first-page":"2829","DOI":"10.1073\/pnas.91.7.2829","article-title":"cell receptor usage by melanoma-specific clonal and highly oligoclonal tumor-infiltrating lymphocyte lines.","volume":"91","author":"Shilyansky","year":"1994","journal-title":"Proc Natl Acad Sci USA."},{"key":"B45","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1002\/(SICI)1097-0215(19960410)66:23.0.CO;2-F","article-title":"Restriction of the T-cell repertoire in tumor-infiltrating lymphocytes from nine patients with renal-cell carcinoma. Relevance of the CDR3 length analysis for the identification of in situ clonal T-cell expansions.","volume":"66","author":"Puisieux","year":"1996","journal-title":"Int J Cancer."},{"key":"B46","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1007\/bf01525987","article-title":"Analysis of T cell receptor alpha beta variability in lymphocytes infiltrating melanoma primary tumours and metastatic lesions.","volume":"39","author":"Scholler","year":"1994","journal-title":"Cancer Immunol Immunother."},{"key":"B47","doi-asserted-by":"publisher","first-page":"146","DOI":"10.1158\/2326-6066.CIR-19-0398","article-title":"TCR Repertoire diversity of peripheral PD-1(+)CD8(+) T cells predicts clinical outcomes after immunotherapy in patients with non-small cell lung cancer.","volume":"8","author":"Han","year":"2020","journal-title":"Cancer Immunol Res."},{"key":"B48","doi-asserted-by":"publisher","DOI":"10.1080\/2162402X.2017.1293210","article-title":"IL15 induces a potent antitumor activity in NK cells isolated from malignant pleural effusions and overcomes the inhibitory effect of pleural fluid.","volume":"6","author":"Croxatto","year":"2017","journal-title":"Oncoimmunology."},{"key":"B49","doi-asserted-by":"publisher","first-page":"7506","DOI":"10.4049\/jimmunol.174.12.7506","article-title":"Release of high mobility group box 1 by dendritic cells controls T cell activation via the receptor for advanced glycation end products.","volume":"174","author":"Dumitriu","year":"2005","journal-title":"J Immunol."},{"key":"B50","doi-asserted-by":"publisher","first-page":"303","DOI":"10.1016\/j.imbio.2008.09.006","article-title":"High mobility group box chromosomal protein 1 acts as a proliferation signal for activated T lymphocytes.","volume":"214","author":"Sundberg","year":"2009","journal-title":"Immunobiology."},{"key":"B51","doi-asserted-by":"publisher","first-page":"399","DOI":"10.6515\/ACS.201809_34(5).20180419A","article-title":"The effects of high mobility group box-1 protein on peripheral Treg\/Th17 balance in patients with atherosclerosis.","volume":"34","author":"Ding","year":"2018","journal-title":"Acta Cardiol Sin."},{"key":"B52","doi-asserted-by":"publisher","first-page":"392","DOI":"10.1038\/s41568-019-0153-5","article-title":"\u03b3\u03b4 T cells: pleiotropic immune effectors with therapeutic potential in cancer.","volume":"19","author":"Silva-Santos","year":"2019","journal-title":"Nat Rev Cancer."},{"key":"B53","doi-asserted-by":"publisher","first-page":"1133","DOI":"10.3892\/ol.2017.6191","article-title":"Characterization of \u03b3\u03b4 T cells in patients with non-small cell lung cancer.","volume":"14","author":"Bao","year":"2017","journal-title":"Oncol Lett."},{"key":"B54","doi-asserted-by":"publisher","first-page":"174","DOI":"10.1165\/rcmb.2018-0201OC","article-title":"17A-Producing \u03b3\u03b4T cells inhibit the formation of malignant pleural effusions.","volume":"61","author":"Wei","year":"2019","journal-title":"Am J Respir Cell Mol Biol."},{"key":"B55","doi-asserted-by":"publisher","first-page":"130","DOI":"10.1165\/rcmb.2019-0080ED","article-title":"\u03b3\u03b4T cells in lung cancer malignant pleural effusion: Friend? Foe?","volume":"61","author":"Moon","year":"2019","journal-title":"Am J Respir Cell Mol Biol."},{"key":"B56","doi-asserted-by":"publisher","DOI":"10.1084\/jem.20190456","article-title":"Targeting the interleukin-17 immune axis for cancer immunotherapy.","volume":"217","author":"Vitiello","year":"2020","journal-title":"J Exp Med."},{"key":"B57","doi-asserted-by":"publisher","first-page":"491","DOI":"10.1084\/jem.20100269","article-title":"Contribution of IL-17\u2013producing \u03b3\u03b4 T cells to the efficacy of anticancer chemotherapy.","volume":"208","author":"Ma","year":"2011","journal-title":"J Exp Med."},{"key":"B58","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2015.00037","article-title":"The Jekyll and Hyde story of IL17-Producing \u03b3\u03b4T Cells.","volume":"6","author":"Patil","year":"2015","journal-title":"Front Immunol."}],"container-title":["Frontiers in Immunology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/article\/10.3389\/fimmu.2020.02027\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,9,4]],"date-time":"2020-09-04T04:29:07Z","timestamp":1599193747000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/article\/10.3389\/fimmu.2020.02027\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,9,4]]},"references-count":58,"alternative-id":["10.3389\/fimmu.2020.02027"],"URL":"https:\/\/doi.org\/10.3389\/fimmu.2020.02027","relation":{},"ISSN":["1664-3224"],"issn-type":[{"value":"1664-3224","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,9,4]]},"article-number":"2027"}}